Literature DB >> 20625814

Relationship between diabetes and risk of second primary contralateral breast cancer.

Christopher I Li1, Janet R Daling, Mei-Tzu C Tang, Kathleen E Malone.   

Abstract

Breast cancer survivors have a substantially higher risk of developing a second primary contralateral breast cancer (CBC) compared to the risk of breast cancer among women in the general population. While data regarding the relationship between diabetes and breast cancer incidence are inconsistent, diabetes is more clearly linked to an elevated risk of all-cause mortality among breast cancer survivors. However, no prior studies have assessed its impact on CBC risk. We assessed the relationship between diabetes, and CBC risk in a population-based nested case-control study consisting of women 40-79 years of age diagnosed with a first primary ER-positive invasive breast cancer. It included 322 women who developed a second primary CBC and 616-matched control women diagnosed only with a first breast cancer. We used conditional logistic regression to quantify associations between diabetes and CBC risk. Compared to women without a history of diabetes, diabetics had a 2.2-fold [95% confidence interval (CI) 1.3-3.6] increased risk of CBC. This risk was more pronounced among women diagnosed with their first breast cancer before age 60 years (odds ratio, OR = 11.5, 95% CI 2.4-54.5), compared to those diagnosed at age 60 years or older (OR = 1.5, 95% CI 0.8-2.7, P for interaction = 0.011). Diabetics diagnosed with breast cancer appear to have an elevated risk of CBC. This is the first study to report this relationship, but if confirmed efforts to insure that diabetic breast cancer survivors are carefully screened for second breast cancers may be warranted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20625814      PMCID: PMC3005863          DOI: 10.1007/s10549-010-1035-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  17 in total

Review 1.  Epidemiology of contralateral breast cancer.

Authors:  Y Chen; W Thompson; R Semenciw; Y Mao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-10       Impact factor: 4.254

Review 2.  Metformin: a therapeutic opportunity in breast cancer.

Authors:  Ana M Gonzalez-Angulo; Funda Meric-Bernstam
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

3.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

Authors:  T Key; P Appleby; I Barnes; G Reeves
Journal:  J Natl Cancer Inst       Date:  2002-04-17       Impact factor: 13.506

4.  Long-term metformin use is associated with decreased risk of breast cancer.

Authors:  Michael Bodmer; Christian Meier; Stephan Krähenbühl; Susan S Jick; Christoph R Meier
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

5.  Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women.

Authors:  Kaoru Hirose; Tatsuya Toyama; Hiroji Iwata; Toshiro Takezaki; Nobuyuki Hamajima; Kazuo Tajima
Journal:  Asian Pac J Cancer Prev       Date:  2003 Jul-Sep

Review 6.  Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

Authors:  Bethany B Barone; Hsin-Chieh Yeh; Claire F Snyder; Kimberly S Peairs; Kelly B Stein; Rachel L Derr; Antonio C Wolff; Frederick L Brancati
Journal:  JAMA       Date:  2008-12-17       Impact factor: 56.272

7.  Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study.

Authors:  Debbie A Lawlor; George Davey Smith; Shah Ebrahim
Journal:  Cancer Causes Control       Date:  2004-04       Impact factor: 2.506

8.  Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study.

Authors:  Pamela J Mink; Eyal Shahar; Wayne D Rosamond; Anthony J Alberg; Aaron R Folsom
Journal:  Am J Epidemiol       Date:  2002-08-15       Impact factor: 4.897

Review 9.  Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence.

Authors:  Fei Xue; Karin B Michels
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

10.  Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer.

Authors:  Tomasz P Srokowski; Shenying Fang; Gabriel N Hortobagyi; Sharon H Giordano
Journal:  J Clin Oncol       Date:  2009-03-23       Impact factor: 44.544

View more
  11 in total

Review 1.  Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle.

Authors:  Carlo La Vecchia; Sharon H Giordano; Gabriel N Hortobagyi; Bruce Chabner
Journal:  Oncologist       Date:  2011-05-31

2.  Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.

Authors:  Gregory S Calip; Rebecca A Hubbard; Andy Stergachis; Kathleen E Malone; Julie R Gralow; Denise M Boudreau
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-06-13       Impact factor: 2.890

Review 3.  Diabetes and cancer I: risk, survival, and implications for screening.

Authors:  Adedayo A Onitilo; Jessica M Engel; Ingrid Glurich; Rachel V Stankowski; Gail M Williams; Suhail A Doi
Journal:  Cancer Causes Control       Date:  2012-05-03       Impact factor: 2.506

4.  Type 2 diabetes mellitus and prognosis in early stage breast cancer women.

Authors:  Muhammet Ali Kaplan; Zafer Pekkolay; Mehmet Kucukoner; Ali Inal; Zuhat Urakci; Hamza Ertugrul; Recai Akdogan; Ugur Firat; Ismail Yildiz; Abdurrahman Isikdogan
Journal:  Med Oncol       Date:  2011-11-15       Impact factor: 3.064

5.  Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis.

Authors:  Lu Chen; Jessica Chubak; Denise M Boudreau; William E Barlow; Noel S Weiss; Christopher I Li
Journal:  Cancer Res       Date:  2017-09-21       Impact factor: 12.701

6.  Associations between diabetes medication use and risk of second breast cancer events and mortality.

Authors:  Gregory S Calip; Onchee Yu; Kent F Hoskins; Denise M Boudreau
Journal:  Cancer Causes Control       Date:  2015-05-09       Impact factor: 2.506

7.  The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women.

Authors:  Nita H Mukand; Naomi Y Ko; Nadia A Nabulsi; Colin C Hubbard; Brian C-H Chiu; Kent F Hoskins; Gregory S Calip
Journal:  Breast Cancer       Date:  2021-11-19       Impact factor: 4.239

8.  Metabolic syndrome and outcomes following early-stage breast cancer.

Authors:  Gregory S Calip; Kathleen E Malone; Julie R Gralow; Andy Stergachis; Rebecca A Hubbard; Denise M Boudreau
Journal:  Breast Cancer Res Treat       Date:  2014-10-10       Impact factor: 4.872

Review 9.  The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer.

Authors:  David P Rose; Peter J Gracheck; Linda Vona-Davis
Journal:  Cancers (Basel)       Date:  2015-10-26       Impact factor: 6.639

10.  The effect of metformin on breast cancer outcomes in patients with type 2 diabetes.

Authors:  Bridget A Oppong; Lindsay A Pharmer; Sabine Oskar; Anne Eaton; Michelle Stempel; Sujata Patil; Tari A King
Journal:  Cancer Med       Date:  2014-06-18       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.